Last reviewed · How we verify
etonogestrel with testosterone undecanoate — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
etonogestrel with testosterone undecanoate (etonogestrel with testosterone undecanoate) — Organon and Co.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| etonogestrel with testosterone undecanoate TARGET | etonogestrel with testosterone undecanoate | Organon and Co | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- etonogestrel with testosterone undecanoate CI watch — RSS
- etonogestrel with testosterone undecanoate CI watch — Atom
- etonogestrel with testosterone undecanoate CI watch — JSON
- etonogestrel with testosterone undecanoate alone — RSS
Cite this brief
Drug Landscape (2026). etonogestrel with testosterone undecanoate — Competitive Intelligence Brief. https://druglandscape.com/ci/etonogestrel-with-testosterone-undecanoate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab